Drug Delivery
Volume 24, 2017 - Issue 1
Open access
3,071
Views
20
CrossRef citations to date
0
Altmetric
Research Article
Improving anti-tumor activity of sorafenib tosylate by lipid- and polymer-coated nanomatrix
Yang Guo1 Beijing Key Laboratory of Molecular Pharmaceutics and New Drug Delivery Systems, School of Pharmaceutical Sciences, Peking University, Beijing, China, ;2 Department of Pharmaceutics, School of Pharmaceutical Sciences, Peking University, Beijing, China, and
, Ting Zhong1 Beijing Key Laboratory of Molecular Pharmaceutics and New Drug Delivery Systems, School of Pharmaceutical Sciences, Peking University, Beijing, China, ;2 Department of Pharmaceutics, School of Pharmaceutical Sciences, Peking University, Beijing, China, and
, Xiao-Chuan Duan1 Beijing Key Laboratory of Molecular Pharmaceutics and New Drug Delivery Systems, School of Pharmaceutical Sciences, Peking University, Beijing, China, ;2 Department of Pharmaceutics, School of Pharmaceutical Sciences, Peking University, Beijing, China, and
, Shuang Zhang1 Beijing Key Laboratory of Molecular Pharmaceutics and New Drug Delivery Systems, School of Pharmaceutical Sciences, Peking University, Beijing, China, ;2 Department of Pharmaceutics, School of Pharmaceutical Sciences, Peking University, Beijing, China, and
, Xin Yao1 Beijing Key Laboratory of Molecular Pharmaceutics and New Drug Delivery Systems, School of Pharmaceutical Sciences, Peking University, Beijing, China, ;2 Department of Pharmaceutics, School of Pharmaceutical Sciences, Peking University, Beijing, China, and
, Yi-Fan Yin1 Beijing Key Laboratory of Molecular Pharmaceutics and New Drug Delivery Systems, School of Pharmaceutical Sciences, Peking University, Beijing, China, ;2 Department of Pharmaceutics, School of Pharmaceutical Sciences, Peking University, Beijing, China, and
, Dan Huang1 Beijing Key Laboratory of Molecular Pharmaceutics and New Drug Delivery Systems, School of Pharmaceutical Sciences, Peking University, Beijing, China, ;2 Department of Pharmaceutics, School of Pharmaceutical Sciences, Peking University, Beijing, China, and
, Wei Ren1 Beijing Key Laboratory of Molecular Pharmaceutics and New Drug Delivery Systems, School of Pharmaceutical Sciences, Peking University, Beijing, China, ;2 Department of Pharmaceutics, School of Pharmaceutical Sciences, Peking University, Beijing, China, and
, Qiang Zhang1 Beijing Key Laboratory of Molecular Pharmaceutics and New Drug Delivery Systems, School of Pharmaceutical Sciences, Peking University, Beijing, China, ;2 Department of Pharmaceutics, School of Pharmaceutical Sciences, Peking University, Beijing, China, and ;3 State Key Laboratory of Natural and Biomimetic Drugs, Peking University, Beijing, China
& Xuan Zhang1 Beijing Key Laboratory of Molecular Pharmaceutics and New Drug Delivery Systems, School of Pharmaceutical Sciences, Peking University, Beijing, China, ;2 Department of Pharmaceutics, School of Pharmaceutical Sciences, Peking University, Beijing, China, and Correspondence[email protected]
show all
Pages 270-277
|
Received 25 Aug 2016, Accepted 03 Oct 2016, Published online: 06 Feb 2017
Reprints and Permissions
This is an open access article distributed under the terms of the Creative Commons CC BY license, which permits unrestricted use, distribution, reproduction in any medium, provided the original work is properly cited.
You are not required to obtain permission to reuse this article in part or whole.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.